(Total Views: 156)
Posted On: 06/25/2019 9:17:07 AM
Post# of 42590
$RGBP Regen BioPharma, Inc. Examines Combining Cannabidiol (CBD) With Its Lead NR2F6 Agonist To Treat for Inflammatory Bowel Disease
https://finance.yahoo.com/news/regen-biopharm...00199.html
https://finance.yahoo.com/news/regen-biopharm...00199.html
(0)
(0)
Scroll down for more posts ▼